These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12741319)

  • 21. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin].
    Tsukamura M; Mizuno S; Toyama H; Ichiyama S
    Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
    J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms.
    Jones SM; Morgan M; Humphrey TJ; Lappin-Scott H
    Lancet; 2001 Jan; 357(9249):40-1. PubMed ID: 11197363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.
    Rothstein DM; Farquhar RS; Sirokman K; Sondergaard KL; Hazlett C; Doye AA; Gwathmey JK; Mullin S; van Duzer J; Murphy CK
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3658-64. PubMed ID: 16940074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biovaluation of the antibacterial flumequine for enteric use.
    Rohlfing SR; Gerster JF; Kvam DC
    J Antimicrob Chemother; 1977 Nov; 3(6):615-20. PubMed ID: 340442
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rifampicin (benemycin) treatment of salmonellosis in nursing infants].
    Vorottyntseva NV; Miliutina LN; Tartakovskaia RA; Khudchenko GV; Shishkevich GI
    Antibiotiki; 1981 Sep; 26(9):706-10. PubMed ID: 7027920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity.
    Carneiro SP; Carvalho KV; de Oliveira Aguiar Soares RD; Carneiro CM; de Andrade MHG; Duarte RS; Dos Santos ODH
    Colloids Surf B Biointerfaces; 2019 Mar; 175():306-313. PubMed ID: 30553206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles as drug carriers for vinblastine. Acute toxicity of vinblastine in a free form and associated to polybutylcyanoacrylate nanoparticles.
    Simeonova M; Ilarionova M; Ivanova T; Konstantinov C; Todorov D
    Acta Physiol Pharmacol Bulg; 1991; 17(4):43-9. PubMed ID: 1841517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
    Wolff M; Nercelles P; Pepay K
    Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
    Ahn JY; Song JY; Yun YS; Jeong G; Choi IS
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):187-97. PubMed ID: 16487300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages.
    Maghrebi S; Thomas N; Prestidge CA; Joyce P
    Drug Deliv Transl Res; 2023 Jun; 13(6):1716-1729. PubMed ID: 36630076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development and estimation of nanosomal rifampicin].
    Oganesian EA; Bud'ko AP; Stukalov IuV; Liubimov II; Biketov SF; Sveshnikov PG; KheĭfetsL B ; Gel'perina SE
    Antibiot Khimioter; 2005; 50(8-9):15-9. PubMed ID: 17016905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Lai CC; Tan CK; Lin SH; Liao CH; Huang YT; Hsueh PR
    J Am Geriatr Soc; 2010 May; 58(5):1001-3. PubMed ID: 20722839
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
    Salem AH; Elkhatib WF; Noreddin AM
    J Pharm Pharmacol; 2011 Jan; 63(1):73-9. PubMed ID: 21155818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
    Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
    Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selection of mutant rifampin-resistant Staphylococcus aureus during the therapeutic use of this antibiotic in combinations. 3 cases].
    Dellamonica P; Bernard E; Etesse H; Brun Y
    Sem Hop; 1983 Dec; 59(44):3087-8. PubMed ID: 6320397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kill the Real with the Fake: Eliminate Intracellular Staphylococcus aureus Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug Carrier.
    Gao F; Xu L; Yang B; Fan F; Yang L
    ACS Infect Dis; 2019 Feb; 5(2):218-227. PubMed ID: 30489062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment.
    Fenaroli F; Westmoreland D; Benjaminsen J; Kolstad T; Skjeldal FM; Meijer AH; van der Vaart M; Ulanova L; Roos N; Nyström B; Hildahl J; Griffiths G
    ACS Nano; 2014 Jul; 8(7):7014-26. PubMed ID: 24945994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.